GCLWW vs CANG vs AUTL vs RERE vs BABA

For growth investors, Autolus Therapeutics plc (AUTL) is the stronger pick with 496.

0% revenue growth year-over-year, versus -52. 7% for Cango Inc. (CANG). Cango Inc. (CANG) offers the better valuation at 5. 7x trailing P/E, making it the more compelling value choice. Analysts rate Cango Inc. (CANG) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Cango Inc.

(CANG) is the cheapest at 5. 7x versus Alibaba Group Holding Limited at 17. 9x. On forward P/E, ATRenew Inc. is actually cheaper at 1. 5x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Cango Inc.

(CANG) delivered a total return of -14. 2%, compared to -73. 2% for ATRenew Inc. (RERE). Over 10 years, the gap is even starker: BABA returned +83. 4% versus AUTL's -93. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), GCL Global Holdings Ltd Warrants (GCLWW) is the lower-risk stock at -1.

52β versus Cango Inc. 's 2. 25β — meaning CANG is approximately -248% more volatile than GCLWW relative to the S&P 500. On balance sheet safety, Cango Inc. (CANG) carries a lower debt/equity ratio of 4% versus 36% for GCL Global Holdings Ltd Warrants — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Autolus Therapeutics plc (AUTL) is pulling ahead at 496.

0% versus -52. 7% for Cango Inc. (CANG). On earnings-per-share growth, the picture is similar: Cango Inc. grew EPS 960. 0% year-over-year, compared to -188. 0% for GCL Global Holdings Ltd Warrants. Over a 3-year CAGR, AUTL leads at 88. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Cango Inc.

(CANG) is the more profitable company, earning 37. 3% net margin versus -21. 8% for Autolus Therapeutics plc — meaning it keeps 37. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CANG leads at 22. 2% versus -23. 9% for AUTL. At the gross margin level — before operating expenses — CANG leads at 55. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, ATRenew Inc.

(RERE) trades at 1. 5x forward P/E versus 4. 1x for Alibaba Group Holding Limited — 2. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CANG: 459. 2% to $3. 00.

In this comparison, BABA (1.

3% yield) pays a dividend. GCLWW, CANG, AUTL, RERE do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, GCL Global Holdings Ltd Warrants (GCLWW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -1.

52)). Cango Inc. (CANG) carries a higher beta of 2. 25 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GCLWW: -68. 7%, CANG: -44. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (GCLWW (Technology) and CANG (Consumer Cyclical) and AUTL (Healthcare) and RERE (Consumer Cyclical) and BABA (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: GCLWW is a small-cap high-growth stock; CANG is a small-cap deep-value stock; AUTL is a small-cap high-growth stock; RERE is a small-cap high-growth stock; BABA is a large-cap deep-value stock. BABA pays a dividend while GCLWW, CANG, AUTL, RERE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.